These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3220909)

  • 1. High-performance liquid chromatography with fluorescence detection of dazmegrel, a specific thromboxane A2 synthetase inhibitor.
    Rebec MV; Skrinska VA
    J Chromatogr; 1988 Nov; 432():375-80. PubMed ID: 3220909
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of UK-38485 (dazmegrel), a specific inhibitor of thromboxane A2 synthetase.
    Rebec MV; Skrinska VA
    Prostaglandins Leukot Essent Fatty Acids; 1989 Dec; 38(3):207-12. PubMed ID: 2622975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the thromboxane synthetase inhibitor 6-(1-imidazolylmethyl)-5,6,7,8-tetrahydronaphthalene-2-carboxylic acid (DP-1904) in human plasma and urine using solid-phase extraction and high-performance liquid chromatography.
    Tanaka M; Ono K; Takegoshi T
    J Chromatogr; 1988 Apr; 426(1):111-9. PubMed ID: 3384863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin concentrations of thromboxane synthetase inhibitor after topical application with bioelastic membrane.
    Wang NZ; Urry DW; Swaim SF; Gillette RL; Hoffman CE; Hinkle SH; Coolman SL; Luan CX; Xu J; Kemppainen BW
    J Vet Pharmacol Ther; 2004 Feb; 27(1):37-43. PubMed ID: 14995965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects on prostanoid formation and pharmacokinetics of dazmegrel (UK-38,485), a novel thromboxane synthase inhibitor, in man.
    Lorenz RL; Fischer S; Wober W; Wagner HA; Weber PC
    Biochem Pharmacol; 1986 Mar; 35(5):761-6. PubMed ID: 3513767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet changes after a saturated fat meal and their prevention by Dazmegrel, a thromboxane synthetase inhibitor.
    Belch JJ; Saniabadi AR; McLaughlin K; Forbes CD
    Lipids; 1987 Mar; 22(3):159-62. PubMed ID: 3573995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dazoxiben, a prototype inhibitor of thromboxane synthesis, has little toxicity in laboratory animals.
    Irisarri E; Kessedjian MJ; Charuel C; Faccini JM; Greaves P; Monro AM; Nachbaur J; Rabémampianina Y
    Hum Toxicol; 1985 May; 4(3):311-5. PubMed ID: 4040117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thromboxane synthetase accentuates hemodynamic instability and burn edema in the anesthetized sheep model.
    LaLonde C; Demling RH
    Surgery; 1989 May; 105(5):638-44. PubMed ID: 2705099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal group B streptococcal sepsis: effects of late treatment with dazmegrel.
    Truog WE; Gibson RL; Juul SE; Henderson WR; Redding GJ
    Pediatr Res; 1988 Apr; 23(4):352-6. PubMed ID: 3287320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium.
    Farber NE; Pieper GM; Gross GJ
    Circulation; 1988 Aug; 78(2):450-61. PubMed ID: 3396181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
    Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
    Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric mucosal protection with selective inhibition of thromboxane synthesis.
    Walt RP; Kemp RT; Filipowicz B; Davies JG; Bhaskar NK; Hawkey CJ
    Gut; 1987 May; 28(5):541-4. PubMed ID: 3474195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioelastic membranes for topical application of a thromboxane synthetase inhibitor for protection of skin from pressure injury: a preliminary study.
    Kemppainen BW; Urry DW; Swaim SF; Sartin EA; Gillette RL; Hinkle SH; Coolman SL; Luan CX; Xu J
    Wound Repair Regen; 2004; 12(4):453-60. PubMed ID: 15260811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the thromboxane synthetase inhibitor dazmegrel (UK 38,485) on skin blood flow in deep partial thickness burns].
    Wang SL
    Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1989 Sep; 5(3):206-9, 239-40. PubMed ID: 2514031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiopulmonary function as related to thromboxane A2 synthesis in experimental septic shock.
    Schützer KM; Lindholm E; Haglund U; Falk A
    Circ Shock; 1988 Sep; 26(1):27-40. PubMed ID: 3056632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selective inhibition of thromboxane synthesis on renal function in humans.
    Zipser RD
    Am J Physiol; 1985 Jun; 248(6 Pt 2):F753-6. PubMed ID: 3839111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Highlights of thromboxane synthetase inhibitor research].
    Yu WG; Xu LN
    Sheng Li Ke Xue Jin Zhan; 1990 Jul; 21(3):216-20. PubMed ID: 2244198
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of a thromboxane synthetase inhibitor on eicosanoid synthesis and glomerular injury during acute unilateral glomerulonephritis in the rat.
    Cook HT; Cattell V; Smith J; Salmon JA; Moncada S
    Clin Nephrol; 1986 Oct; 26(4):195-202. PubMed ID: 3490944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the thromboxane synthetase inhibitor, dazmegrel (UK 38,485), on pulmonary gas exchange and hemodynamics in neonatal sepsis.
    Truog WE; Sorensen GK; Standaert TA; Redding GJ
    Pediatr Res; 1986 May; 20(5):481-6. PubMed ID: 3520468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of prostaglandin E2 in acute necrotising pancreatitis in rats.
    van Ooijen B; Kort WJ; Tinga CJ; Wilson JH; Westbroek DL
    Gut; 1989 May; 30(5):671-4. PubMed ID: 2731761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.